| 20529-4 |
FLUoxetine |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
FLUoxetine [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20529-4 |
|
Confirm |
|
|
Both |
|
|
|
0 |
FLUoxetine Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; Prozac; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.73 |
1.0m |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 2053-7 |
Carotene |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Carotene [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ug/dL |
|
|
|
|
|
|
CHEM |
|
2053-7 |
|
|
|
|
Both |
|
|
|
0 |
Carotene SerPl-mCnc |
|
|
|
Y |
|
Beta carotene; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pro vitamin A; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders |
2.73 |
1 |
|
|
|
|
|
|
|
ug/dL |
|
|
Release 2.70: SYSTEM: Updated System from "Ser" as this test can be run on both serum and plasma.; |
0 |
| 20530-2 |
Haloperidol |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Haloperidol [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20530-2 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Haloperidol Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Haldol; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serenace; UA; UR; Urn |
2.73 |
1.0m |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 20531-0 |
Hydroxyalprazolam |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
DEPRECATED |
Deprecated Hydroxyalprazolam [Mass/volume] in Urine by Confirm method |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
20531-0 |
|
Confirm |
|
|
|
|
|
|
0 |
Deprecated OH-Alpraz Ur Cfm-mCnc |
|
|
|
|
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Hydroxy alprazolam; Hydroxyalpraz; LC/MS/MS; Level; Mass concentration; OH-Alpraz; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.36 |
1.0m |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 20532-8 |
Hydroxyethylflurazepam |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Hydroxyethylflurazepam [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20532-8 |
|
Confirm |
|
|
Both |
|
|
|
0 |
OH-Ethylfluraz Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; GCMS; Hydroxy ethylflurazepam; LC/MS/MS; Level; Mass concentration; OH-Ethylfluraz; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.73 |
1.0m |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 20533-6 |
Hydroxytriazolam |
PrThr |
Urine |
Pt |
Ord |
Confirm |
|
ACTIVE |
Hydroxytriazolam [Presence] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
20533-6 |
|
Confirm |
|
|
Both |
|
|
|
0 |
OH-Triazolam Ur Ql Cfm |
|
|
|
|
|
Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Hydroxy triazolam; Illicit; LC/MS/MS; OH-Triazolam; OHTRZ; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Triazolam metabolite; UA; UR; Urn |
2.73 |
1.0m |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 20534-4 |
Hydroxytriazolam |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
DEPRECATED |
Deprecated Hydroxytriazolam [Mass/volume] in Urine by Confirm method |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
20534-4 |
|
Confirm |
|
|
|
|
|
|
0 |
Deprecated OH-Triazolam Ur Cfm-mCnc |
|
|
|
|
|
Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Hydroxy triazolam; Illicit; LC/MS/MS; Level; Mass concentration; OH-Triazolam; OHTRZ; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Triazolam metabolite; UA; UR; Urn |
2.36 |
1.0m |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 20535-1 |
Hydroxytriazolam cutoff |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Hydroxytriazolam cutoff [Mass/volume] in Urine for Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20535-1 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
OH-Triazolam CtO Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; Hydroxy triazolam; LC/MS/MS; Level; Mass concentration; OH-Triazolam; OHTRZ; Point in time; QNT; Quan; Quant; Quantitative; Random; Triazolam metabolite; UA; UR; Urn |
2.44 |
1.0m |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 20536-9 |
Hydroxytriazolam cutoff |
MCnc |
Urine |
Pt |
Qn |
Screen |
|
ACTIVE |
Hydroxytriazolam cutoff [Mass/volume] in Urine for Screen method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20536-9 |
|
Screen |
|
|
Observation |
|
|
|
0 |
OH-Triazolam CtO Ur Scn-mCnc |
|
|
|
Y |
|
CtO; DRUG/TOXICOLOGY; Drugs; Hydroxy triazolam; Level; Mass concentration; OH-Triazolam; OHTRZ; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; Triazolam metabolite; UA; UR; Urn |
2.44 |
1.0m |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 20537-7 |
Ketamine |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Ketamine [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20537-7 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Ketamine Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Ketalar; Ketaset; Ketavet; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.73 |
1.0m |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 20538-5 |
Methotrimeprazine |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Methotrimeprazine [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20538-5 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Methotrimeprazine Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Hirnamin; LC/MS/MS; Lepurin; Lerium; Levamin; Level; Levohalte; Levomazine; Levomeprazine; Levomeproma; Levomepromazin; Levomepromazina; Levomepromazine; Levomezine; Levonormal; Levopromazine; Levoprome; Levotomin; Levozan; Levozin; Mass concentration; Methotrimeprazine; Milezin; Minozinan; Neozine; Neuractil; Neurocil; Neurozil; Novo-Meprazine; Nozinan; Point in time; Procrazine; QNT; Quan; Quant; Quantitative; Random; Ronexine; Sinogan; Sofmin; Specia 246; Tisercin; Tisercine; Tisercinetta; Tisercinettes; UA; UR; Urn; Veractil |
2.52 |
1.0m |
|
|
|
|
|
|
|
ug/mL |
|
|
Changed component from Levomepromazine to to Methotrimeprazine to reflect the current International Nonproprietary Name (INN) which is also listed as the USAN and the BAN name at the present. There may be some countries that still use Levomeprazine which we made a synonym. |
0 |
| 20539-3 |
Levomepromazine |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
DEPRECATED |
Deprecated Levomepromazine [Mass/volume] in Urine by Confirm method |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
20539-3 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Deprecated L-Mepromazine Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.36 |
1.0m |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 2054-5 |
Catalase |
CCnc |
RBC |
Pt |
Qn |
|
|
ACTIVE |
Catalase [Enzymatic activity/volume] in Red Blood Cells |
|
MIN |
DefinitionDescription |
|
|
U/mL RBC |
|
|
|
|
|
|
CHEM |
|
2054-5 |
|
|
|
|
Both |
|
|
|
0 |
Catalase RBC-cCnc |
|
|
|
Y |
|
Catalytic Concentration; Chemistry; Erythrocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles |
2.44 |
1 |
|
|
|
|
|
|
|
U/mL{RBCs} |
|
|
|
0 |
| 20540-1 |
Levorphanol |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Levorphanol [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20540-1 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Levorphanol Ur Cfm-mCnc |
|
|
|
Y |
|
Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Dromoran; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Levo-dromoran; Levorphan; Mass concentration; Methorphinan; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.42 |
1.0m |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 20541-9 |
Lormetazepam |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Lormetazepam [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20541-9 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Lormetazepam Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.42 |
1.0m |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 20542-7 |
Lysergate diethylamide |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Lysergate diethylamide [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20542-7 |
|
Confirm |
|
|
Both |
|
|
|
0 |
LSD Ur Cfm-mCnc |
|
|
|
Y |
|
Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; LSD; Lysergic acid; Lysergic acid diethylamide; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.73 |
1.0m |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 20543-5 |
Mescaline |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Mescaline [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20543-5 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Mescaline Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Peyote; Peyotl; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.42 |
1.0m |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 20544-3 |
Mesoridazine |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Mesoridazine [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20544-3 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Mesoridazine Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Mesoridazine besylate; Point in time; QNT; Quan; Quant; Quantitative; Random; Serentil; UA; UR; Urn |
2.42 |
1.0m |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 20545-0 |
Methylenedioxyamphetamine |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Methylenedioxyamphetamine [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20545-0 |
|
Confirm |
|
|
Both |
|
|
|
0 |
MDA Ur Cfm-mCnc |
|
|
|
Y |
|
Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; MDA; Methylenedioxymethamphetamine metabolite; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.73 |
1.0m |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 20546-8 |
Methylenedioxyamphetamine cutoff |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Methylenedioxyamphetamine cutoff [Mass/volume] in Urine for Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20546-8 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
MDA CtO Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; MDA; Methylenedioxymethamphetamine metabolite; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.73 |
1.0m |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 20547-6 |
MethylePHEDrine |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
MethylePHEDrine [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20547-6 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Me-ePHEDrine Ur Cfm-mCnc |
|
|
|
Y |
|
Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Ivilco; LC/MS/MS; Level; Mass concentration; Me-ePHEDrine; Pholcomed; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tossamine plus; UA; UR; Urn |
2.42 |
1.0m |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 20548-4 |
Methylphenidate |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Methylphenidate [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20548-4 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Me-phenidate Ur Cfm-mCnc |
|
|
|
Y |
|
Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Me-phenidate; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Ritalin; UA; UR; Urn |
2.73 |
1.0m |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 20549-2 |
Methyprylon |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Methyprylon [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20549-2 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Methyprylon Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Methprylon; Noludar; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.42 |
1.0m |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 2055-2 |
Catecholamines |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Catecholamines [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
CHEM |
|
2055-2 |
|
|
|
|
Both |
|
|
|
0 |
Catechols Bld-mCnc |
|
|
|
Y |
|
Blood; Cate; Catec; Catech; Catechol; Catecholamine; Catecholamines.total; Catechols; Chemistry; Epinephrine+norepinephrine+dopamine; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.5 |
1 |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
| 20550-0 |
Morphine.free |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Morphine Free [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20550-0 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Morphine Free Ur Cfm-mCnc |
|
|
|
Y |
|
c260; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; FR; GCMS; LC/MS/MS; Level; Mass concentration; Morphine Free; Morphine sulfate; MS; MSO4; Non-protein bound; OMPH; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; unconjugated morphine; UR; Urn |
2.73 |
1.0m |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
